NCT01841632View on ClinicalTrials.gov

Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Liver Transplantation
Interventions
DRUG

MultiStem

Trial Locations (1)

93053

Department of Surgery, University Hospital Regensburg, Regensburg

Sponsors

Collaborators (1)

Healios K.K.
All Listed Sponsors
collaborator

University Hospital Regensburg

OTHER

collaborator

Healios K.K.

INDUSTRY

lead

Prof. Dr. Marc-H. Dahlke, Ph. D.

OTHER

NCT01841632 - Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation | Biotech Hunter | Biotech Hunter